Titan Bio-Tech [TITANBIO] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

Titan Bio-Tech Ltd.

BSE
Loading...

Panacea Biotec Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Titan Bio-Tech Ltd. wins in 13 metrics, Panacea Biotec Ltd. wins in 5 metrics, with 0 ties. Titan Bio-Tech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Titan Bio-Tech Ltd. Panacea Biotec Ltd. Better
P/E Ratio (TTM) 74.64 182.62 Titan Bio-Tech Ltd.
Price-to-Book Ratio 12.19 2.65 Panacea Biotec Ltd.
Debt-to-Equity Ratio 5.32 2.79 Panacea Biotec Ltd.
PEG Ratio -1.22 -15.02 Titan Bio-Tech Ltd.
EV/EBITDA 61.34 -65.87 Titan Bio-Tech Ltd.
Profit Margin (TTM) 14.13% -1.29% Titan Bio-Tech Ltd.
Operating Margin (TTM) 16.92% 1.99% Titan Bio-Tech Ltd.
EBITDA Margin (TTM) 16.92% 1.99% Titan Bio-Tech Ltd.
Return on Equity 14.04% -1.01% Titan Bio-Tech Ltd.
Return on Assets (TTM) 12.32% -0.65% Titan Bio-Tech Ltd.
Free Cash Flow (TTM) $106.79M $-776.74M Titan Bio-Tech Ltd.
Dividend Yield 0.42% N/A N/A
1-Year Return 419.45% 18.85% Titan Bio-Tech Ltd.
Price-to-Sales Ratio (TTM) 10.54 3.61 Panacea Biotec Ltd.
Enterprise Value $20.35B $19.26B Titan Bio-Tech Ltd.
EV/Revenue Ratio 10.57 3.18 Panacea Biotec Ltd.
Gross Profit Margin (TTM) N/A 58.88% N/A
Revenue per Share (TTM) $47 $99 Panacea Biotec Ltd.
Earnings per Share (Diluted) $6.58 $-1.28 Titan Bio-Tech Ltd.
Beta (Stock Volatility) -0.48 0.14 Titan Bio-Tech Ltd.

Titan Bio-Tech Ltd. vs Panacea Biotec Ltd. Stock Performance Analysis

Loading Price Chart...

TITANBIO
PANACEABIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Titan Bio-Tech Ltd.0.80%3.09%-1.02%28.03%96.24%110.92%
Panacea Biotec Ltd.0.90%-2.19%39.94%70.71%51.42%43.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Titan Bio-Tech Ltd.419.45%756.94%499.88%6,742.31%9,962.22%20,395.39%
Panacea Biotec Ltd.18.85%307.76%44.67%440.21%276.43%141.23%

Performance & Financial Health Analysis: Titan Bio-Tech Ltd. vs Panacea Biotec Ltd.

MetricTITANBIOPANACEABIO
Market Information
Market Cap i₹19.90B₹21.84B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i68,890168,211
90 Day Avg. Volume i156,601144,184
Last Close₹448.30₹540.80
52 Week Range₹74.73 - ₹555.65₹292.40 - ₹647.00
% from 52W High-19.32%-16.41%
All-Time High₹1,460.00 (Feb 18, 2026)₹647.00 (Jun 09, 2026)
% from All-Time High-69.29%-16.41%
Growth Metrics
Quarterly Revenue Growth0.48%0.01%
Quarterly Earnings Growth0.94%-0.12%
Financial Health
Profit Margin (TTM) i0.14%-0.01%
Operating Margin (TTM) i0.17%0.02%
Return on Equity (TTM) i0.14%-0.01%
Debt to Equity (MRQ) i5.322.79
Cash & Liquidity
Book Value per Share (MRQ)₹40.29₹134.77
Cash per Share (MRQ)₹0.87₹13.86
Operating Cash Flow (TTM) i₹197.75M₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹215.32M₹-83,700,000
Dividends
Last 12-Month Dividend Yield i0.42%N/A
Last 12-Month Dividend i₹4.00₹0.00

Valuation & Enterprise Metrics Analysis: Titan Bio-Tech Ltd. vs Panacea Biotec Ltd.

MetricTITANBIO (Apr 24, 2026)PANACEABIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i74.64182.62
Forward P/E iN/AN/A
PEG Ratio i-1.22-15.02
Price to Sales (TTM) i10.543.61
Price to Book (MRQ) i12.192.65
Market Capitalization
Market Capitalization i₹19.90B₹21.84B
Enterprise Value i₹20.35B₹19.26B
Enterprise Value Metrics
Enterprise to Revenue i10.573.18
Enterprise to EBITDA i61.34-65.87
Risk & Other Metrics
Beta i-0.480.14
Book Value per Share (MRQ) i₹40.29₹134.77

Financial Statements Comparison: Titan Bio-Tech Ltd. vs Panacea Biotec Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTITANBIO (2025)PANACEABIO (2025)
Revenue/Sales i1.56B4.93B
Cost of Goods Sold i892.53M2.36B
COGS % of Revenue i57.0%47.9%
Gross Profit i671.98M2.57B
Gross Margin i43.0%52.1%
Research & Development iN/AN/A
Operating Income (EBIT) i212.57M-556.12M
Operating Margin i13.6%-11.3%
EBITDA i285.61M-76.28M
EBITDA Margin i18.3%-1.5%
Pre-Tax Income i243.67M-79.48M
Pre-Tax Income % of Revenue i15.6%-1.6%
Income Tax i60.96M7.71M
Income Tax % of Revenue i3.9%0.2%
Net Income (Profit) i215.32M-87.19M
Profit Margin i13.8%-1.8%

Balance Sheet & Liquidity Metrics

MetricTITANBIO (2025)PANACEABIO (2025)
Cash & Equivalents i51.28M821.25M
Total Current Assets i790.38M5.45B
Total Current Assets % of Revenue i50.5%110.7%
Total Current Liabilities i177.36M3.67B
Total Current Liabilities % of Revenue i11.3%74.5%
Long-Term Debt i4.19M150.00M
Long-Term Debt % of Revenue i0.3%3.0%
Total Shareholders Equity i1.53B8.31B
Retained Earnings i1.36B7.80B
Retained Earnings % of Revenue i87.0%158.3%
Property, Plant & Equipment i571.62M5.43B

Cash Flow Statement Comparison

MetricTITANBIO (2025)PANACEABIO (2025)
Operating Cash Flow i197.75M-1.51B
Operating Cash Flow % of Revenue i12.6%-30.7%
Capital Expenditures i-85.26M-497.30M
Free Cash Flow i106.79M-776.74M
FCF Margin i6.8%-15.8%
Debt Repayment i-2.69M0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTITANBIOPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i41.32M61.25M
Float Shares i13.13M15.42M
% Held by Insiders i68.21%72.65%
% Held by Institutions i0.00%0.13%
% Held by Public i31.79%27.22%

Dividend Analysis & Yield Comparison: Titan Bio-Tech Ltd. vs Panacea Biotec Ltd.

MetricTITANBIOPANACEABIO
Last 12-Month Dividend i₹4.00₹0.00
Last 12-Month Dividend Yield i0.42%N/A
3-Year Avg Annual Dividend i₹1.93₹0.00
3-Year Avg Dividend Yield i0.34%N/A
3-Year Total Dividends i₹5.80₹0.00
Ex-Dividend DateSep 19, 2025N/A